BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, January 16, 2026
See today's BioWorld
Home
» Algeta Stock Surges on $2.5B Offer from Xofigo Partner Bayer
To read the full story,
subscribe
or
sign in
.
Algeta Stock Surges on $2.5B Offer from Xofigo Partner Bayer
Nov. 27, 2013
By
Cormac Sheridan
Shares in Algeta ASA surged by 30 percent Tuesday as partner Bayer AG offered NOK336 (US$55.03) per share for the Norwegian firm, which values the company at NOK16.8 billion, or about $2.7 billion ($2.5 billion net its current cash).
BioWorld